Condition: Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture · Abdominal Aortic Aneurysm Without Rupture · Thoracic Aortic Aneurysm Without Rupture · Sponsor: Rede Optimus Hospitalar SA
Shockwave TEVAR is a nonrandomized, prospective, international, multi-center, PMCF, obervational study. The aim of this study is to evaluate the outcomes of the Shockwave™ Peripheral Intravascular Lithotripsy Balloon (Shockwave Medical Inc.) in the routine treatment of hostile iliac accesses during TEVAR and F/BEVAR.
This description comes directly from the study's public registry record.
Phina Muna, Dr. · +49 157 80 58 5869 · phina.muna@redeoptimus.com
Annelena Held-Wehmöller, Dr. · +49 157 85128140 · annelena.held@redeoptimus.com
Always discuss trial participation with your own doctor first.
| Department of Vascular Surgery, LMU Hospital Munich | Münich, Bavaria, Germany | Recruiting |
| Department of Vascular Surgery, Klinikum Nürnberg Campus Süd | Nuremberg, Bavaria, Germany | Recruiting |
| University of Genoa School of Medicine, Ospedale Policlinico San Martino - HSM | Genoa, Liguria, Italy | Recruiting |
| Azienda Ospedaliera Universitaria Integrata di Verona | Verona, Veneto, Italy | Recruiting |
| Inselspital, University Hospital Bern, Heart Vascular Center | Bern, Canton Bern, Switzerland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06332911